Trial intelligence / Profile preview

Effects of rosuvastatin on glucose metabolism in non-diabetic renal transplant recipients

2005-002777-68Phase 4Completed

Sponsor
Cardiff and Vale University Health Board
Start
Jul 2006
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of rosuvastatin in post-transplantation diabetes mellitus (PTDM), diabetes mellitus (DM) and dyslipidemia, sponsored by Cardiff and Vale University Health Board. Primary endpoint: Disposition index change. Started Jul 2006; status: completed.

02

Drugs

rosuvastatin
03

Conditions

post-transplantation diabetes mellitus (PTDM)diabetes mellitus (DM)dyslipidemia

Beyond the preview

Go deeper on 2005-002777-68.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-002777-68.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call